![IHC-P analysis of formalin fixed human placenta tissue using GTX52511 BMPR2 antibody [9A10]. IHC-P analysis of formalin fixed human placenta tissue using GTX52511 BMPR2 antibody [9A10].](https://www.genetex.com/upload/website/prouct_img/normal/GTX52511/GTX52511_20191119_IHC-P_w_23060900_351.webp)
IHC-P analysis of formalin fixed human placenta tissue using GTX52511 BMPR2 antibody [9A10].
BMPR2 antibody [9A10]
GTX52511
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetBMPR2
Overview
- SupplierGeneTex
- Product NameBMPR2 antibody [9A10]
- Delivery Days Customer9
- Antibody SpecificityThis antibody was selected for its ability to detect human BMPR2. No cross reactivity was found to BMP R1A and R1B.
- Application Supplier NoteWB: 1:100 - 1:1000. IHC-P: 1:50 - 1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID9A10
- Concentration200 ug/ml
- ConjugateUnconjugated
- Gene ID659
- Target nameBMPR2
- Target descriptionbone morphogenetic protein receptor type 2
- Target synonymsBMP type II receptor; BMP type-2 receptor; BMPR3; BMPR-II; BMR2; bone morphogenetic protein receptor type II; bone morphogenetic protein receptor type-2; bone morphogenetic protein receptor, type II (serine/threonine kinase); BRK-3; POVD1; PPH1; T-ALK; type II activin receptor-like kinase; type II receptor for bone morphogenetic protein-4
- HostMouse
- IsotypeIgG1
- Protein IDQ13873
- Protein NameBone morphogenetic protein receptor type-2
- Scientific DescriptionThis gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of two different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension, both familial and fenfluramine-associated, and with pulmonary venoocclusive disease. [provided by RefSeq, Jul 2008]
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203